Extracellular vesicles for inhalation

A technology of vesicles and cells, which is applied in the treatment of respiratory diseases, compositions containing vesicles, and the field of exosomes, which can solve problems such as the inability to obtain information about nebulized administration of exosomes, and the inability to solve mucus barriers or cell membrane barriers

Pending Publication Date: 2021-03-26
欧姆尼斯普兰特有限公司
View PDF5 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

These exosomes are not coated and do not address the mucus barrier or the cell membrane barrier
Although the literature suggests administration by injection or inhalation, no information is available on nebulized administration of exosomes required for inhalation

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Extracellular vesicles for inhalation
  • Extracellular vesicles for inhalation
  • Extracellular vesicles for inhalation

Examples

Experimental program
Comparison scheme
Effect test

specific Embodiment approach

[0097] In order to facilitate the understanding of the invention, a specific embodiment and variants thereof will now be described by way of example with reference to the accompanying drawings, in which:

[0098] Figure 1A and 1B is a graph of the concentration and size of non-PEGylated exosomes and PEGylated exosomes using Nanoparticle Tracking Analysis (NTA);

[0099] Figure 2A and 2B Zeta potential distributions of PEGylated exosomes and non-PEGylated exosomes are shown.

[0100] Figures 3A-3F is a series of transmission electron microscopy images of PEGylated and non-PEGylated exosomes.

[0101] Figures 4A-4E A series of flow cytometry images of MSCs and exosomes labeled with Far-Red dye.

[0102] Figures 5A-5C are confocal microscopy images of treated and untreated exosomes that have entered cystic fibrosis bronchial epithelial cells, which first penetrated the mucus layer in air-liquid interface culture.

[0103] Figure 6a and 6b is the nanoparticle track...

Embodiment 1

[0127] The purpose of this example is to isolate exosomes from human mesenchymal stem cells (hMSCs) and efficiently modify their surface with low molecular weight lipid-modified polyethylene glycol (lipid-PEG) to improve aerosolization and mucus penetration properties of exosomes.

[0128] Fluorescence labeling of hMSCs

[0129] Frozen bone marrow MSCs (donor #163) were thawed and directly inoculated into 15 T-175 cells in EV-depleted complete medium (CCM) containing 10 ng / ml human basic fibroblast growth factor (bFGF). flasks (1 x 10 per flask 6 cells) were passaged when they reached 80-85% confluency. Cells were aggregated and resuspended in PBS before being pelleted and mixed with 2 μg far-infrared dye (excitation / emission ~630 / 661 nm) (cell tracking) / 1 × 10 6 Cells are incubated in the dark for 20 min (this will label the exosomes with a far-infrared dye-labeled cytosolic protein). After incubation, MSC medium was added to stop the reaction and incubated for an addit...

Embodiment 2

[0167]The purpose of this example is to show that the surface modification of exosomes can be effectively achieved, and a genetically engineered mesenchymal stem cell population of bioengineered cells overexpressing the CFTR gene can be successfully established.

[0168] BT-20 and hMSC cell line culture technology

[0169] will come from HTB-19 TM BT-20 cells as BT-20 human epithelial cells were cultured in DMEM medium supplemented with 10% FBS and 100 IU / ml penicillin / streptomycin as complete conditioned medium (CCM). Human mesenchymal stem cell donor No. 096 in Gibco MEM Alpha medium containing 10% FBS and 100 lU / ml penicillin / streptomycin and 1 ng / ml human basic fibroblast growth factor (bFGF) was used to cultivate.

[0170] Cells were fed 3 days per week using an aseptic technique in which spent media was removed from the culture flask with a pipette and added to a waste bottle, which was then replenished with an appropriate amount of fresh media (including suppleme...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
molecular weightaaaaaaaaaa
diameteraaaaaaaaaa
Login to view more

Abstract

Vesicles, including exosomes, having a coating of a hydrophilic, neutral polymer such a PEG have an increased ability to form a suspension or colloid compared to uncoated vesicles, this enables the coated vesicles to be used to form aerosol droplets such that a liquid formulation containing vesicles can be used in a nebulizer for inhaled administration thereof. The coated vesicles are also able topass through mucus and can deliver their cargo into lung cells. Exosomes from mesenchymal stem cells can deliver additional proteins, miRs, mRNAs and other nucleic acid sequences to lung cells providing a regenerative gene therapy for CF, COPD lung cancer and other lung diseases.

Description

technical field [0001] The present invention relates to extracellular vesicles, especially exosomes, compositions containing vesicles, their use and methods of use and production. The invention also relates to the use of such vesicles in therapy and gene therapy, in particular for the treatment of respiratory diseases such as cystic fibrosis (CF), COPD and lung cancer. Background technique [0002] Extracellular vesicles are nanoscale membranous vesicles that are encapsulated by lipid bilayers and actively secreted by most prokaryotic and eukaryotic cells. Extracellular vesicles include exosomes, microvesicles and membrane vesicles. [0003] Typically, vesicles are formed by exocytosis in living cells. Exosomes differ from many other extracellular vesicles in that they originate in the endocytic compartment of the cell and are expelled from the cell by exocytosis when the multivesicular body fuses with the cell membrane. [0004] The formation of multivesicular bodies is ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K9/127A61K48/00A61K9/00
CPCA61K9/0078A61K9/1271C12N15/87C12N2740/16043A61K48/0091A61K9/5068A61K48/0075A61P11/00A61P35/00A61M11/005
Inventor 杰拉德·伯纳德·麦考利
Owner 欧姆尼斯普兰特有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap